A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

Type of Cancer
Unknown

Sponsor
Incyte

Protocol Number
INCB 39110-301

To Learn More Call
201-510-0910